Abnormal STMN2 transcripts were detected in the amygdala of 20 out of 38 patients and in the entorhinal cortex of 13 out of 27 patients with Alzheimer’s disease, and none of the control individuals (Sup. Here, STMN2 is linked to Alzheimer disease.